ReviewFrontiers in psychiatry2026
Ketamine as an NMDA-modulating therapy in bipolar disorder: rationale and evidence.
R Queissner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewFrontiers in psychiatry2026
R Queissner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.